Literature DB >> 21355940

Fibroblasts and myofibroblasts in renal fibrosis.

Soma Meran1, Robert Steadman.   

Abstract

Interstitial fibrosis, associated with extensive accumulation of extracellular matrix constituents in the cortical interstitium, is directly correlated to progression of renal disease. The earliest histological marker of this progression is the accumulation in the interstitium of fibroblasts with the phenotypic appearance of myofibroblasts. These myofibroblasts are contractile cells that express alpha smooth muscle actin and incorporate it into intracellular stress fibres. Although fibroblasts are histologically visible in normal kidneys, there are relatively few of them and proximal tubular epithelial cells predominate. In progressive disease, however, the interstitium becomes filled with myofibroblasts. In this review, we will examine the phenotype and function of fibroblasts and myofibroblasts in the cortical interstitium and the processes that may modulate them.
© 2011 The Authors. International Journal of Experimental Pathology © 2011 International Journal of Experimental Pathology.

Entities:  

Mesh:

Year:  2011        PMID: 21355940      PMCID: PMC3101489          DOI: 10.1111/j.1365-2613.2011.00764.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  123 in total

Review 1.  Specificity, diversity, and regulation in TGF-beta superfamily signaling.

Authors:  E Piek; C H Heldin; P Ten Dijke
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

2.  Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro.

Authors:  C C Chipev; R Simman; G Hatch; A E Katz; D M Siegel; M Simon
Journal:  Cell Death Differ       Date:  2000-02       Impact factor: 15.828

Review 3.  Epithelial-mesenchymal transformation of renal tubular epithelial cells in vitro and in vivo.

Authors:  H Okada; T Inoue; H Suzuki; F Strutz; E G Neilson
Journal:  Nephrol Dial Transplant       Date:  2000       Impact factor: 5.992

Review 4.  Signal transduction by the TGF-beta superfamily.

Authors:  Liliana Attisano; Jeffrey L Wrana
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

5.  The deletion of transforming growth factor-beta-induced myofibroblasts depends on growth conditions and actin organization.

Authors:  P D Arora; C A McCulloch
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

6.  Expression of CD44 in kidney after acute ischemic injury in rats.

Authors:  A J Lewington; B J Padanilam; D R Martin; M R Hammerman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-01       Impact factor: 3.619

7.  Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast.

Authors:  M B Vaughan; E W Howard; J J Tomasek
Journal:  Exp Cell Res       Date:  2000-05-25       Impact factor: 3.905

8.  Hyaluronan binding properties of a CD44 chimera containing the link module of TSG-6.

Authors:  Jayne Lesley; Nicole M English; István Gál; Katalin Mikecz; Anthony J Day; Robert Hyman
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

9.  Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation.

Authors:  F Strutz; M Zeisberg; B Hemmerlein; B Sattler; K Hummel; V Becker; G A Müller
Journal:  Kidney Int       Date:  2000-04       Impact factor: 10.612

10.  Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.

Authors:  Youxin Yang; Marie-Claire Gubler; Hélène Beaufils
Journal:  Nephron       Date:  2002-07       Impact factor: 2.847

View more
  131 in total

1.  A role for fibrocytes in peritoneal fibrosis?

Authors:  Timothy Bowen
Journal:  Perit Dial Int       Date:  2012 Jan-Feb       Impact factor: 1.756

Review 2.  Cellular and molecular mechanisms of renal fibrosis.

Authors:  Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

3.  The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling.

Authors:  Petros Andrikopoulos; Julius Kieswich; Sabrina Pacheco; Luxme Nadarajah; Steven Michael Harwood; Caroline E O'Riordan; Christoph Thiemermann; Muhammad M Yaqoob
Journal:  J Am Soc Nephrol       Date:  2018-12-10       Impact factor: 10.121

Review 4.  Collagen matrix as a tool in studying fibroblastic cell behavior.

Authors:  Jiří Kanta
Journal:  Cell Adh Migr       Date:  2015-03-03       Impact factor: 3.405

5.  Silencing SMOC2 ameliorates kidney fibrosis by inhibiting fibroblast to myofibroblast transformation.

Authors:  Casimiro Gerarduzzi; Ramya K Kumar; Priyanka Trivedi; Amrendra K Ajay; Ashwin Iyer; Sarah Boswell; John N Hutchinson; Sushrut S Waikar; Vishal S Vaidya
Journal:  JCI Insight       Date:  2017-04-20

Review 6.  Renal interstitial fibrosis: mechanisms and evaluation.

Authors:  Alton B Farris; Robert B Colvin
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

Review 7.  The myofibroblast matrix: implications for tissue repair and fibrosis.

Authors:  Franco Klingberg; Boris Hinz; Eric S White
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

8.  Secreted Frizzled-related protein 1 (Sfrp1) regulates the progression of renal fibrosis in a mouse model of obstructive nephropathy.

Authors:  Makoto Matsuyama; Akane Nomori; Kyomi Nakakuni; Akihiko Shimono; Masaki Fukushima
Journal:  J Biol Chem       Date:  2014-09-24       Impact factor: 5.157

Review 9.  Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies.

Authors:  António Nogueira; Maria João Pires; Paula Alexandra Oliveira
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

10.  Cardiac Fibrotic Remodeling on a Chip with Dynamic Mechanical Stimulation.

Authors:  Ming Kong; Junmin Lee; Iman K Yazdi; Amir K Miri; Yi-Dong Lin; Jungmok Seo; Yu Shrike Zhang; Ali Khademhosseini; Su Ryon Shin
Journal:  Adv Healthc Mater       Date:  2019-01-04       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.